195 related articles for article (PubMed ID: 26096932)
1. Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells.
Boudjadi S; Carrier JC; Groulx JF; Beaulieu JF
Oncogene; 2016 Mar; 35(13):1671-8. PubMed ID: 26096932
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the Integrin α1β1 in the Progression of Colorectal Cancer.
Boudjadi S; Bernatchez G; Sénicourt B; Beauséjour M; Vachon PH; Carrier JC; Beaulieu JF
Cancers (Basel); 2017 Jul; 9(8):. PubMed ID: 28933766
[TBL] [Abstract][Full Text] [Related]
3. Integrin α1 promotes tumorigenicity and progressive capacity of colorectal cancer.
Li H; Wang Y; Rong SK; Li L; Chen T; Fan YY; Wang YF; Yang CR; Yang C; Cho WC; Yang J
Int J Biol Sci; 2020; 16(5):815-826. PubMed ID: 32071551
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2.
Cheli Y; Kanaji S; Jacquelin B; Chang M; Nugent DJ; Kunicki TJ
Biochim Biophys Acta; 2007; 1769(9-10):546-58. PubMed ID: 17669516
[TBL] [Abstract][Full Text] [Related]
5. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
Lee MF; Hsieh NT; Huang CY; Li CI
J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
[TBL] [Abstract][Full Text] [Related]
6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
7. Identification of Response Elements on Promoters Using Site-Directed Mutagenesis and Chromatin Immunoprecipitation.
Boudjadi S; Carrier JC; Beaulieu JF
Methods Mol Biol; 2018; 1765():43-56. PubMed ID: 29589300
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations are involved in the overexpression of glutathione S-transferase π-1 in human colorectal cancers.
Zhang R; Kang KA; Piao MJ; Kim KC; Zheng J; Yao CW; Cha JW; Maeng YH; Chang WY; Moon PG; Baek MC; Hyun JW
Int J Oncol; 2014 Sep; 45(3):1275-83. PubMed ID: 24970398
[TBL] [Abstract][Full Text] [Related]
11. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.
Yochum GS; Cleland R; Goodman RH
Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
[TBL] [Abstract][Full Text] [Related]
14. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
15. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
16. c-Myc inhibits CD11a and CD11c leukocyte integrin promoters.
López-Rodríguez C; Delgado MD; Puig-Kröger A; Nueda A; Muñoz E; León J; Bernabéu C; Corbi AL
Eur J Immunol; 2000 Sep; 30(9):2465-71. PubMed ID: 11009078
[TBL] [Abstract][Full Text] [Related]
17. EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells.
Ferraro A; Mourtzoukou D; Kosmidou V; Avlonitis S; Kontogeorgos G; Zografos G; Pintzas A
Int J Biochem Cell Biol; 2013 Feb; 45(2):243-54. PubMed ID: 23116973
[TBL] [Abstract][Full Text] [Related]
18. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
19. Expression of the human antimicrobial peptide β-defensin-1 is repressed by the EGFR-ERK-MYC axis in colonic epithelial cells.
Bonamy C; Sechet E; Amiot A; Alam A; Mourez M; Fraisse L; Sansonetti PJ; Sperandio B
Sci Rep; 2018 Dec; 8(1):18043. PubMed ID: 30575780
[TBL] [Abstract][Full Text] [Related]
20. Surface-bound galectin-4 regulates gene transcription and secretion of chemokines in human colorectal cancer cell lines.
Rao US; Rao PS
Tumour Biol; 2017 Mar; 39(3):1010428317691687. PubMed ID: 28345468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
